8 March 2006





Molecular Connections and Plasma Proteome Institute

collaborate in developing Plasma Protein Database


Bangalore, India - Molecular Connections Pvt Ltd today announced collaboration with Dr.Leigh Anderson’s Plasma Proteome institute to develop a biomarker focused plasma protein database curating published literature.


The completely hand-curated database aims at assisting biomarker discovery, by acting as an effective functional and diagnostic utility in assessing effective disease markers or pathological indicators.


The Plasma Protein database would be developed by Molecular Connection scientists in Bangalore curating thousands of papers on clinically significant proteins with their protein concentrations in the plasma under pathological conditions.


Dr. Leigh Anderson stated ”PPI welcomes the opportunity to use, and help extend, this  general resource of protein information, particularly as it addresses the important areas of biomarker evaluation, prioritization and validation. ”


Commenting on the collaboration, Mr Jignesh Bhate, Founder of Molecular Connections mentioned, “Molecular Connections would leverage its literature mining and curation expertise to develop the PPD. We are privileged to collaborate with Dr Leigh Anderson and PPI for the same.”


About the Plasma Proteome Institute:


Plasma Proteome Institute is a non-profit Institute aims to enable major advances in disease diagnosis using results from the expanding field of proteomics combined with new technologies for the analysis of proteins in blood. http://www.plasmaproteome.org


About Molecular Connections:


Molecular Connections (www.molecularconnections.com) provides high quality, cost effective text mining, literature curation and annotation services as well as develops databases in the areas of genomics, proteomics, ADME Tox, clinical diseases, drugs, chemistry, patents. Dr.Limsoon Wong  (HTTP://WWW.COMP.NUS.EDU.SG/~wongls) is the Chairman of Molecular Connections. Customers of Molecular Connections include leading pharmaceutical and biotechnology discovery companies, genomics and proteomics companies, medical technology and equipment companies and leading academic laboratories.